Skip to main content
SpringerPlus

Table 3 Changes in clinical data of diabetes mellitus complicated by liver cirrhosis

From: Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury

 

LC group (n = 19)

Pre-treatment

Post-treatment

P value

HbA1c (%)

8.12 ± 1.29

7.38 ± 1.24

0.006

AST (IU/L)

60.4 ± 30.9

64.5 ± 33.3

0.628

ALT (IU/L)

49.5 ± 28.4

44.5 ± 24.3

0.483

γGT (IU/L)

277.6 ± 310.4

212.7 ± 277.5

0.237

Back to article page